SCHEMBL2107693

SCHEMBL2107693

Nc1ccccc1NC(=O)c1ccc(CC(C(=O)Nc2ccccc2)C(=O)Nc2ccccc2)cc1Br

nearest known ligand 0.70

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 19/20 0.70
HDAC3 O15379 8/20 0.49
HDAC2 Q92769 8/20 0.49
NCOR2 Q9Y618 3/20 0.48
HDAC10 Q969S8 4/20 0.44
HDAC11 Q96DB2 4/20 0.44
MAPK1 P28482 1/20 0.43
HDAC4 P56524 3/20 0.43
HDAC7 Q8WUI4 3/20 0.43
HDAC8 Q9BY41 3/20 0.43
HDAC6 Q9UBN7 3/20 0.43
HDAC9 Q9UKV0 3/20 0.43
HDAC5 Q9UQL6 3/20 0.43
MEN1 O00255 1/20 0.42
NPC1 O15118 1/20 0.42
LMNA P02545 1/20 0.42
HTT P42858 1/20 0.42
RAB9A P51151 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1753913 0.84 HDAC1 (0.66) HDAC1HDAC3HDAC2NCOR2HDAC10
SCHEMBL2108446 0.82 HDAC1 (1.00) HDAC1HDAC3HDAC2NCOR2HDAC10
SCHEMBL2108840 0.82 HDAC1 (0.64) HDAC1HDAC3HDAC2NCOR2HDAC10
SCHEMBL2107907 0.79 ALDH1A1 (0.51) HDAC1MEN1NPC1LMNARAB9A
SCHEMBL2108597 0.77 HDAC1 (0.69) HDAC1HDAC3HDAC2NCOR2HDAC10
SCHEMBL1754060 0.74 HDAC1 (0.83) HDAC1HDAC3HDAC2NCOR2
SCHEMBL1689418 0.74 HDAC1 (0.78) HDAC1HDAC3HDAC2NCOR2HDAC8
SCHEMBL2108848 0.72 HDAC1 (0.76) HDAC1HDAC3HDAC2
SCHEMBL1689196 0.72 HDAC1 (0.78) HDAC1HDAC3HDAC2NCOR2HDAC10
SCHEMBL1689269 0.72 HDAC1 (0.73) HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1896395-B1 MODIFIED MALONATE DERIVATIVES MERCK SHARP & DOHME (US) 2015-07-15 EP claimed
US-8158825-B2 Modified malonate derivatives MERCK SHARP & DOHME CORP. (US) 2012-04-17 US claimed
US-20100160327-A1 Modified Malonate Derivatives MERCK SHARP & DOHME LLC 2010-06-24 US claimed
EP-1896395-B1 MODIFIED MALONATE DERIVATIVES MERCK SHARP & DOHME (US) 2015-07-15 EP disclosed
US-8158825-B2 Modified malonate derivatives MERCK SHARP & DOHME CORP. (US) 2012-04-17 US disclosed
US-20100160327-A1 Modified Malonate Derivatives MERCK SHARP & DOHME LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160327-A1 Modified Malonate Derivatives ME2, ME3, ME1 HDAC1 6/4885HDAC3 17/4885HDAC2 42/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.